Tag: Cancer: Laryngeal
AI Pipeline Can Accurately Measure Sarcopenia in Head and Neck Cancer
Skeletal muscle index-derived sarcopenia associated with worse overall survival, longer feeding tube duration
Overweight Tied to Better Head, Neck Cancer Outcomes After Chemoradiotherapy
Benefits seen for complete metabolic response after chemoradiotherapy, survival, and locoregional failure
Uncontrolled Heart Risk Factors Common in Head, Neck Squamous Cell Cancer
Black race linked to increased risk of uncontrolled risk factors; higher rates for patients with larynx cancer
Model Can Predict Postoperative RT Delay in Head & Neck Cancer
Model incorporating individual-level factors with health literacy and community-level factors most predictive of postoperative radiation therapy delay
Quitting Smoking Tied to Better Survival in Head, Neck Squamous Cell Carcinoma
Greatest benefit seen for former smokers who quit >10 years before diagnosis
Outcomes Worse for Black Patients With Head, Neck Cancer in Clinical Trials
Outcomes worse for Black versus White patients enrolled in clinical trials that minimize access to care, socioeconomic status confounders
Gabapentin May Cut Opioid Needs for Oral Mucositis Pain During RT
Findings seen in studies involving patients receiving chemoradiotherapy for nonmetastatic squamous cell carcinoma of head and neck
Oropharyngeal Cancer Incidence, Mortality Up Among U.S. Men
Geographic differences seen, with notable rises in the Midwest and Southeast
Incidence of Oropharyngeal Cancer Projected to Rise in U.S. Men
Under a status quo scenario based on current levels of HPV vaccination, 792,000 OPC cases in men would be prevented by the year 2100
Epigenetic Age Acceleration Up in Head and Neck Cancer
Correlation found for increased EAA with elevated fatigue, which was mediated by inflammatory markers CRP, IL-6
